These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 5671692

  • 1. [Plasminogen, antiplasmins and the rate of fibrinolysis in hypertension and atherosclerosis].
    Gritsiuk AI.
    Kardiologiia; 1968 May; 8(5):54-8. PubMed ID: 5671692
    [No Abstract] [Full Text] [Related]

  • 2. Blood coagulation and fibrinolysis.
    Heimburger N, Trobisch H.
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract] [Full Text] [Related]

  • 3. [Factors of the fibrinolysis of the vascular wall in patients with different severity of atherosclerosis and of different age].
    Kovalenko AN.
    Biull Eksp Biol Med; 1982 Jan; 93(1):26-8. PubMed ID: 7199953
    [No Abstract] [Full Text] [Related]

  • 4. [Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)].
    Guseĭnov ChS, Golovastova GI, Gorelova AM, Cherenkova GM, Mikhailova ND.
    Lab Delo; 1976 Jan; (5):276-83. PubMed ID: 62085
    [No Abstract] [Full Text] [Related]

  • 5. Biological effects of the administration of an equimolar streptokinase-plasminogen complex in man.
    Verstraete M, Vermylen J, Holleman W, Barlow GH.
    Thromb Res; 1977 Aug; 11(2):227-36. PubMed ID: 905974
    [No Abstract] [Full Text] [Related]

  • 6. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A, Vermylen J, Verstraete M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969 Aug; 92(1):7-19. PubMed ID: 4189377
    [No Abstract] [Full Text] [Related]

  • 7. [Activator and inhibitor of fibrinolysis in the genital organs of the rat in the course of pregnancy].
    Januszko T, Buluk K.
    Acta Physiol Pol; 1966 Aug; 17(4):569-80. PubMed ID: 6007876
    [No Abstract] [Full Text] [Related]

  • 8. Depressed endogenous fibrinolytic activity in essential hypertension.
    Tsapogas MJ, Peabody RA, Wu KT, Devaraj KT, Eckert C.
    J Cardiovasc Surg (Torino); 1974 Aug; 15(6):651-4. PubMed ID: 4281429
    [No Abstract] [Full Text] [Related]

  • 9. Antiplasmins.
    Norman PS.
    Fed Proc; 1966 Aug; 25(1):63-7. PubMed ID: 4143744
    [No Abstract] [Full Text] [Related]

  • 10. Does D-dimer formation in patients undergoing cardiopulmonary bypass (CPB) reflect primary fibrinolysis?
    Whitten CW.
    J Cardiothorac Vasc Anesth; 1997 Jun; 11(4):537-8. PubMed ID: 9188011
    [No Abstract] [Full Text] [Related]

  • 11. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971 Jun; 16():159-90. PubMed ID: 5004447
    [No Abstract] [Full Text] [Related]

  • 12. [The state of the blood fibrinolytic system in rabbits with experimental atherosclerosis].
    Nikitin IuP, Tabarovskaia TA.
    Biull Eksp Biol Med; 1968 Nov; 66(11):20-2. PubMed ID: 5758116
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro].
    Golubenkova NI.
    Lab Delo; 1981 Nov; (12):720-2. PubMed ID: 6172641
    [No Abstract] [Full Text] [Related]

  • 15. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG.
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Altered endogenous fibrinolysis and biochemical factors in atherosclerosis.
    Peabody RA, Tsapogas MJ, Wu KT, Deveraj KT, Karmody AM, Eckert C.
    Arch Surg; 1974 Aug; 109(2):309-13. PubMed ID: 4276947
    [No Abstract] [Full Text] [Related]

  • 18. [Thromboembolic complications, the coagulation and fibrinolytic blood system in heart defects with pronounced circulatory insufficiency].
    Gritsiuk AI.
    Kardiologiia; 1969 Sep; 9(9):21-8. PubMed ID: 4244024
    [No Abstract] [Full Text] [Related]

  • 19. Thrombolysis.
    Sharp AA.
    Adv Cardiol; 1970 Sep; 4():225-32. PubMed ID: 4250170
    [No Abstract] [Full Text] [Related]

  • 20. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G.
    Minerva Ginecol; 1969 Jul 31; 21(14):888-92. PubMed ID: 4249426
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.